Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Blood Advances|December 11, 2025
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphomaSasanka M Handunnetti, Amit Khot, Piers Blombery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2024
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)Ing Soo Tiong, Devendra K Hiwase, Emad Abro, et al.
Communications Biology|October 22, 2020
Cep55 overexpression promotes genomic instability and tumorigenesis in miceDebottam Sinha, Purba Nag, Devathri Nanayakkara, et al.
Blood|May 11, 2021
Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cellsKenneth P Micklethwaite, Kavitha Gowrishankar, Brian S Gloss, et al.
Blood|September 1, 2021
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLLPiers Blombery, Thomas E Lew, Michael A Dengler, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 24, 2025
The PreGen Research Program: Implementing Prenatal Genomic Testing in Australia-A CommentarySarah Long, Deborah Schofield, Josh Kraindler, et al.
Pageof 16